Net margin is the percentage of revenue a company keeps as profit after every expense and tax. It is net income divided by revenue, and the table shows both amounts beside the percentage. A higher net margin means more of each sales dollar reaches the bottom line. One-time gains, write-downs and tax items pass through net income, so a single period's net margin can move for reasons unrelated to the underlying business. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.
Indivior Pharmaceuticals, Inc. net margin for the quarter ending 2026-06-30 was 35.57%, a 496.76% increase year-over-year.
Indivior Pharmaceuticals, Inc. net margin for the quarter ending 2026-03-31 was 28.08%, a 58.90% increase year-over-year.
Indivior Pharmaceuticals, Inc. net margin for the quarter ending 2025-12-31 was 28.49%, a 305.67% increase year-over-year.
Indivior Pharmaceuticals, Inc. net margin for the quarter ending 2025-09-30 was 13.38%, a 86.65% increase year-over-year.
Indivior Pharmaceuticals, Inc. net margin for fiscal 2025 was 16.95%, a 2776.51% increase from fiscal 2024.
Indivior Pharmaceuticals, Inc. net margin for fiscal 2024 was 0.59%, a change of 12.12% from fiscal 2023.
Indivior Pharmaceuticals, Inc. net margin for fiscal 2023 was -11.53%, a change of -6.64% from fiscal 2022.
Indivior Pharmaceuticals, Inc. net margin for fiscal 2022 was -4.88%.